PARPi, BRCA, and gaps: controversies and future research
Trends in Cancer · 2024-09 · 10 (9) · 857-869
DOI: 10.1016/j.trecan.2024.06.008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2024-09. Verfasst von Diego Dibitetto und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Länggassstrasse 122, 3012 Bern, Switzerland; Bern Center for Precision Medicine…. Hauptthemen laut MEDLINE: Poly(ADP-ribose) Polymerase Inhibitors, BRCA2 Protein, BRCA1 Protein. Die Arbeit wurde bisher 93-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In recent years, various poly(ADP-ribose) polymerase (PARP) inhibitors (PARPis) have been approved for the treatment of several cancers to target the vulnerability of homologous recombination (HR) deficiency (e.g., due to BRCA1/2 dysfunction). In this review we analyze the ongoing debates and recent breakthroughs in the use of PARPis for BRCA1/2-deficient cancers, juxtaposing the 'double-strand break (DSB)' and 'single-stranded DNA (ssDNA) gap' models of synthetic lethality induced by PARPis. We spotlight the complexity of this interaction, highlighting emerging research on the role of DNA polymerase theta (POLθ) and ssDNA gaps in shaping therapy responses. We scrutinize the clinical ramifications of these findings, especially concerning PARPi efficacy and resistance mechanisms, underscoring the heterogeneity of BRCA-mutated tumors and the urgent need for advanced research to bridge the gap between laboratory models and patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Länggassstrasse 122, 3012 Bern, Switzerland; Bern Center for Precision Medicine and Cancer Therapy Research Cluster, Department for Biomedical Resear…
Zitieren
APA
Dibitetto, D., Widmer, C. A., & Rottenberg, S. (2024). PARPi, BRCA, and gaps: controversies and future research. Trends in Cancer, 10(9), 857-869. https://doi.org/10.1016/j.trecan.2024.06.008
Vancouver
Dibitetto D, Widmer CA, Rottenberg S. PARPi, BRCA, and gaps: controversies and future research. Trends in Cancer. 2024;10(9):857-869. doi:10.1016/j.trecan.2024.06.008
BibTeX
@article{Dibitetto2024,
author = {Dibitetto, Diego and Widmer, Carmen A and Rottenberg, Sven},
title = {PARPi, BRCA, and gaps: controversies and future research},
journal = {Trends in Cancer},
year = {2024},
volume = {10},
number = {9},
pages = {857--869},
doi = {10.1016/j.trecan.2024.06.008}
}
EUVIMED